The Src pathway as a therapeutic strategy
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology,Molecular Medicine
Reference42 articles.
1. Novel insights into c-Src;Alper;Curr. Pharm. Des.,2005
2. Src family tyrosine kinases and growth factor signaling;Abram;Exp. Cell Res.,2000
3. Src protein-tyrosine kinase structure and regulation;Roskoski;Biochem. Biophys. Res. Commun.,2004
4. Structure and regulation of Src family kinases;Boggon;Oncogene,2004
5. c-Src and cooperating partners in human cancer;Ishizawar;Cancer Cell,2004
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. How the structural properties of the indole derivatives are important in kinase targeted drug design?: A case study on tyrosine kinase inhibitors;Bioorganic & Medicinal Chemistry;2022-01
2. Hsp90 dependence of a kinase is determined by its conformational landscape;Scientific Reports;2017-03-14
3. Tris DBA palladium overcomes hypoxia-mediated drug resistance in multiple myeloma;Leukemia & Lymphoma;2015-11-16
4. Cytotoxic activity assessment, QSAR and docking study of novel bis-carboxamide derivatives of 4-pyrones synthesized by Ugi four-component reaction;European Journal of Medicinal Chemistry;2013-08
5. 9,10-Secosteroids, protein kinase inhibitors from the Chinese gorgonian Astrogorgia sp.;Bioorganic & Medicinal Chemistry;2011-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3